Edoxaban
DU176b-C-U313
Phase 3 small_molecule completed
Quick answer
Edoxaban for Cardiac Disease is a Phase 3 program (small_molecule) at Daiichi Sankyo with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Daiichi Sankyo
- Indication
- Cardiac Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed